I to mindre undersøgelser (238 patienter) vurderedes virkningen af Xeloda som redningsbehandling efter svigt af taxaner og antracykliner.
Two smaller studies (238 patients) have also looked at the effectiveness of Xeloda after failure of treatment with taxanes and anthracyclines.